Advertisement

Topics

Are we on the verge of a biosimilars breakthrough in the USA?

12:29 EDT 22 Aug 2017 | thePharmaLetter

A total of 32 biosimilar products, based on 12 biologics, have been approved for use in the European…

Original Article: Are we on the verge of a biosimilars breakthrough in the USA?

NEXT ARTICLE

More From BioPortfolio on "Are we on the verge of a biosimilars breakthrough in the USA?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...